myeloproliferative disorder

Treatment is based on the type of myeloproliferative disorder the patient has.

When this was taken into account, only 11.2% developed myeloproliferative disorders.

There are different types of treatment for patients with chronic myeloproliferative disorders.

There is no standard staging system for chronic myeloproliferative disorders.

Phlebotomy is used in this way to treat some chronic myeloproliferative disorders.

She was a national expert in the blood diseases referred to as Myeloproliferative Disorders.

Chronic myeloproliferative disorders sometimes become acute leukemia, in which too many abnormal white blood cells are made.

Radiation therapy to treat myeloproliferative disorders is usually directed at the spleen.

Trials of these inhibitors are in progress for the treatment of the other myeloproliferative disorders.

It is one of four myeloproliferative disorders.

Splenomegaly or hepatosplenomegaly may occasionally be present in association with an overlapping myeloproliferative disorder.

Chronic myeloproliferative disorders include the following 6 types:

CML is one of a group of diseases called the myeloproliferative disorders.

However it is a common feature of myeloproliferative disorders and particularly prominent in chronic myelogenous leukemia.

Transient myeloproliferative disorder (TMD) usually goes away on its own.

In myeloproliferative disorders too many blood stem cells develop into one or more types of blood cells.

Blood and immune causes: chronic neutropenia and myeloproliferative disorders.

The type of myeloproliferative disorder is based on whether too many red blood cells, white blood cells, or platelets are being made.

For more information from the National Cancer Institute about chronic myeloproliferative disorders, see the following:

High counts may lead to thrombosis, although this is mainly when the elevated count is due to myeloproliferative disorder.

Tumors with trilineage hematopoiesis occurring with transformation of chronic myeloproliferative disorders.

Interferon alfa is a biologic agent commonly used to treat some chronic myeloproliferative disorders.

Myeloproliferative disorders (Increased numbers of cells)

Tests that examine the blood and bone marrow are used to detect (find) and diagnose chronic myeloproliferative disorders.

Tefferi A. Myeloproliferative disorders: essential thrombocythemia and primary myelofibrosis.